News & Media

Press Releases

Amolyt Pharma Launches Public Awareness Campaign to Honor World Hypoparathyroidism Awareness Day

June 1, 2023

Download a PDF: EN or FR

Amolyt Pharma Announces Oral Presentation at the 25^th European Congress of Endocrinology (ECE) 2023

May 11, 2023

Download a PDF: EN or FR

Amolyt Pharma Announces Abstracts Accepted for Presentation at ECE and ENDO

May 5, 2023

Download a PDF: EN or FR

Presentations

AZP-3813

Repeated Treatment with AZP-3813, a Bicyclic, 16-Amino Acid Peptide Antagonist of the Human Growth Hormone Receptor, Induces Enhanced Suppression of IGF1 in Beagle Dogs. ENDO 2023 Poster.

Written by

Dan Hennings

Eneboparatide (AZP-3601)

Eneboparatide, a Novel PTH-1 Receptor Agonist, Has No Impact on Bone Parameters Following Chronic Treatment of Non-Human Primates. ECE 2023 Presentation.

Written by

Dan Hennings

Eneboparatide (AZP-3601)

Eneboparatide, a Novel PTH-1 Receptor Agonist, Induces Rapid Reduction and Normalization of Urinary Calcium in Chronic Hypoparathyroid Patients. ECE 2023 Poster.

Written by

Dan Hennings

Eneboparatide (AZP-3601)

Eneboparatide, a Novel PTH-1 Receptor Agonist, Induces Rapid Reduction and Normalization of Urinary Calcium in Chronic Hypoparathyroid Patients. ECE 2023 Presentation.

Written by

Dan Hennings

Eneboparatide (AZP-3601)

Treatment of Chronic Hypoparathyroidism by Eneboparatide, a Novel PTH Receptor-1 Agonist: Results from a Phase 2a Study. ECE 2023 Presentation.

Written by

Dan Hennings

Upcoming events

J.P. Morgan 42^nd Annual Healthcare Conference (JPM)

Date: January 8-11, 2024 (San Francisco, CA)

Rare Disease Day

Date: February 29, 2024

26^th European Congress of Endocrinology (ECE)

Date: May 11-14, 2024 (Stockholm, Sweden)

World Hypoparathyroidism Awareness Day

Date: June 1, 2024

2024 Endocrine Society Meeting (ENDO)

Date: June 1-4, 2024 (Boston, MA)

BIO International Convention

Date: June 3-6, 2024 (San Diego, CA)

American Society for Bone and Mineral Research 2024 Annual Meeting (ASBMR)

Date: September 27-30, 2024 (Toronto, Canada)

40^th Congress of the French Society of Endocrinology

Date: October 16-18, 2024 (Clermont-Ferrand, France)

Acromegaly Awareness Day

Date: November 1, 2024

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Analytics" category.
cookielawinfo-checkbox-functional	1 year	Set by the GDPR Cookie Consent plugin, this cookie stores user consent for cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Necessary" category.
CookieLawInfoConsent	1 year	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
elementor	never	The website's WordPress theme uses this cookie. It allows the website owner to implement or change the website's content in real-time.
viewed_cookie_policy	1 year	The GDPR Cookie Consent plugin sets the cookie to store whether or not the user has consented to use cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	1 year 1 month 4 days	Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*	1 year 1 month 4 days	Google Analytics sets this cookie to store and count page views.

News & Media

Press Releases

Presentations

Upcoming events

Social Updates

TWITTER